Literature DB >> 25931201

Effects of impaired membrane interactions on α-synuclein aggregation and neurotoxicity.

Daniel Ysselstein1, Mehul Joshi1, Vartika Mishra1, Amy M Griggs1, Josephat M Asiago1, George P McCabe2, Lia A Stanciu3, Carol Beth Post1, Jean-Christophe Rochet4.   

Abstract

The post-mortem brains of individuals with Parkinson's disease (PD) and other synucleinopathy disorders are characterized by the presence of aggregated forms of the presynaptic protein α-synuclein (aSyn). Understanding the molecular mechanism of aSyn aggregation is essential for the development of neuroprotective strategies to treat these diseases. In this study, we examined how interactions between aSyn and phospholipid vesicles influence the protein's aggregation and toxicity to dopaminergic neurons. Two-dimensional NMR data revealed that two familial aSyn mutants, A30P and G51D, populated an exposed, membrane-bound conformer in which the central hydrophobic region was dissociated from the bilayer to a greater extent than in the case of wild-type aSyn. A30P and G51D had a greater propensity to undergo membrane-induced aggregation and elicited greater toxicity to primary dopaminergic neurons compared to the wild-type protein. In contrast, the non-familial aSyn mutant A29E exhibited a weak propensity to aggregate in the presence of phospholipid vesicles or to elicit neurotoxicity, despite adopting a relatively exposed membrane-bound conformation. Our findings suggest that the aggregation of exposed, membrane-bound aSyn conformers plays a key role in the protein's neurotoxicity in PD and other synucleinopathy disorders.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aggregation; Familial mutation; Membrane; Neurodegeneration; Oligomer; Parkinson's disease; Phospholipid; Vesicle; α-Helix; α-Synuclein

Mesh:

Substances:

Year:  2015        PMID: 25931201      PMCID: PMC4458405          DOI: 10.1016/j.nbd.2015.04.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  90 in total

1.  Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Christopher M Dobson; Ad Bax
Journal:  J Mol Biol       Date:  2009-05-27       Impact factor: 5.469

2.  Adsorption of alpha-synuclein on lipid bilayers: modulating the structure and stability of protein assemblies.

Authors:  Farzin Haque; Anjan P Pandey; Lee R Cambrea; Jean-Christophe Rochet; Jennifer S Hovis
Journal:  J Phys Chem B       Date:  2010-03-25       Impact factor: 2.991

3.  SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.

Authors:  Lise Giehm; Cristiano Luis Pinto Oliveira; Gunna Christiansen; Jan Skov Pedersen; Daniel E Otzen
Journal:  J Mol Biol       Date:  2010-06-09       Impact factor: 5.469

4.  Interplay of alpha-synuclein binding and conformational switching probed by single-molecule fluorescence.

Authors:  Allan Chris M Ferreon; Yann Gambin; Edward A Lemke; Ashok A Deniz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

5.  The first N-terminal amino acids of alpha-synuclein are essential for alpha-helical structure formation in vitro and membrane binding in yeast.

Authors:  Katherina Vamvaca; Michael J Volles; Peter T Lansbury
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

6.  Alpha-synuclein binds large unilamellar vesicles as an extended helix.

Authors:  Adam J Trexler; Elizabeth Rhoades
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

7.  Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.

Authors:  Damla Pinar Karpinar; Madhu Babu Gajula Balija; Sebastian Kügler; Felipe Opazo; Nasrollah Rezaei-Ghaleh; Nora Wender; Hai-Young Kim; Grit Taschenberger; Björn H Falkenburger; Henrike Heise; Ashutosh Kumar; Dietmar Riedel; Lars Fichtner; Aaron Voigt; Gerhard H Braus; Karin Giller; Stefan Becker; Alf Herzig; Marc Baldus; Herbert Jäckle; Stefan Eimer; Jörg B Schulz; Christian Griesinger; Markus Zweckstetter
Journal:  EMBO J       Date:  2009-09-10       Impact factor: 11.598

8.  Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells.

Authors:  Mordhwaj S Parihar; Arti Parihar; Masayo Fujita; Makoto Hashimoto; Pedram Ghafourifar
Journal:  Int J Biochem Cell Biol       Date:  2009-05-19       Impact factor: 5.085

9.  Acceleration of α-synuclein aggregation by exosomes.

Authors:  Marie Grey; Christopher J Dunning; Ricardo Gaspar; Carl Grey; Patrik Brundin; Emma Sparr; Sara Linse
Journal:  J Biol Chem       Date:  2014-11-25       Impact factor: 5.157

10.  Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.

Authors:  Christina R Bodner; Alexander S Maltsev; Christopher M Dobson; Ad Bax
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

View more
  35 in total

Review 1.  Dynamic structural flexibility of α-synuclein.

Authors:  Danielle E Mor; Scott E Ugras; Malcolm J Daniels; Harry Ischiropoulos
Journal:  Neurobiol Dis       Date:  2015-12-31       Impact factor: 5.996

2.  Pikuni-Blackfeet traditional medicine: Neuroprotective activities of medicinal plants used to treat Parkinson's disease-related symptoms.

Authors:  Aurélie de Rus Jacquet; Mitali Arun Tambe; Sin Ying Ma; George P McCabe; Jay Hansford C Vest; Jean-Christophe Rochet
Journal:  J Ethnopharmacol       Date:  2017-01-11       Impact factor: 4.360

Review 3.  Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.

Authors:  Maria Nguyen; Yvette C Wong; Daniel Ysselstein; Alex Severino; Dimitri Krainc
Journal:  Trends Neurosci       Date:  2018-11-30       Impact factor: 13.837

4.  Assembly of α-synuclein aggregates on phospholipid bilayers.

Authors:  Zhengjian Lv; Mohtadin Hashemi; Siddhartha Banerjee; Karen Zagorski; Jean-Christophe Rochet; Yuri L Lyubchenko
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-06-19       Impact factor: 3.036

5.  Semisynthetic and in Vitro Phosphorylation of Alpha-Synuclein at Y39 Promotes Functional Partly Helical Membrane-Bound States Resembling Those Induced by PD Mutations.

Authors:  Igor Dikiy; Bruno Fauvet; Ana Jovičić; Anne-Laure Mahul-Mellier; Carole Desobry; Farah El-Turk; Aaron D Gitler; Hilal A Lashuel; David Eliezer
Journal:  ACS Chem Biol       Date:  2016-07-11       Impact factor: 5.100

6.  Selective dopaminergic neurotoxicity of three heterocyclic amine subclasses in primary rat midbrain neurons.

Authors:  Angela Cruz-Hernandez; Zeynep Sena Agim; Paola C Montenegro; George P McCabe; Jean-Christophe Rochet; Jason R Cannon
Journal:  Neurotoxicology       Date:  2018-03       Impact factor: 4.294

7.  Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.

Authors:  Chiharu Mizuguchi; Fuka Ogata; Shiho Mikawa; Kohei Tsuji; Teruhiko Baba; Akira Shigenaga; Toshinori Shimanouchi; Keiichiro Okuhira; Akira Otaka; Hiroyuki Saito
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

Review 8.  Dynamic behaviors of α-synuclein and tau in the cellular context: New mechanistic insights and therapeutic opportunities in neurodegeneration.

Authors:  Fred Yeboah; Tae-Eun Kim; Anke Bill; Ulf Dettmer
Journal:  Neurobiol Dis       Date:  2019-07-24       Impact factor: 5.996

9.  Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).

Authors:  Cristian Follmer; Eduardo Coelho-Cerqueira; Danilo Y Yatabe-Franco; Gabriel D T Araujo; Anderson S Pinheiro; Gilberto B Domont; David Eliezer
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

10.  Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.

Authors:  Vanderlei de Araújo Lima; Lucas Alex do Nascimento; David Eliezer; Cristian Follmer
Journal:  ACS Chem Neurosci       Date:  2018-11-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.